135 related articles for article (PubMed ID: 15030283)
1. Use of GPIIb/IIIa inhibitors in cardiovascular medicine.
Ahrens I; Peter K; Bode C
Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):233-42. PubMed ID: 15030283
[TBL] [Abstract][Full Text] [Related]
2. GPIIb-IIIa receptor inhibitors: what the interventional radiologist needs to know.
Hofmann LV; Razavi M; Arepally A; Reginelli JP; Resar J; Geschwind JF; Corl F
Cardiovasc Intervent Radiol; 2001; 24(6):361-7. PubMed ID: 11907740
[TBL] [Abstract][Full Text] [Related]
3. Anti-GPIIb/IIIa drugs: current strategies and future directions.
Coller BS
Thromb Haemost; 2001 Jul; 86(1):427-43. PubMed ID: 11487034
[TBL] [Abstract][Full Text] [Related]
4. GP IIb/IIIa blockade during peripheral artery interventions.
Tepe G; Wiskirchen J; Pereira P; Claussen CD; Miller S; Duda SH
Cardiovasc Intervent Radiol; 2008; 31(1):8-13. PubMed ID: 17479207
[TBL] [Abstract][Full Text] [Related]
5. Platelet glycoprotein IIb/IIIa inhibitors.
Rosove MH
Best Pract Res Clin Haematol; 2004 Mar; 17(1):65-76. PubMed ID: 15171958
[TBL] [Abstract][Full Text] [Related]
6. Use of glycoprotein IIb/IIIa receptor inhibitors in acute coronary syndromes.
Lepor NE
Rev Cardiovasc Med; 2002; 3 Suppl 1():S3-S12. PubMed ID: 12439431
[TBL] [Abstract][Full Text] [Related]
7. GPIIb/IIIa antagonists: pathophysiologic and therapeutic insights from studies of c7E3 Fab.
Coller BS
Thromb Haemost; 1997 Jul; 78(1):730-5. PubMed ID: 9198247
[TBL] [Abstract][Full Text] [Related]
8. Use of glycoprotein IIb/IIIa platelet inhibitors in peripheral vascular interventions.
Ansel GM; George BS; Botti CF; Silver MJ
Rev Cardiovasc Med; 2002; 3 Suppl 1():S35-40. PubMed ID: 12439435
[TBL] [Abstract][Full Text] [Related]
9. Controversies surrounding platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention and acute coronary syndromes.
Harrington RA
Semin Thromb Hemost; 2004 Dec; 30(6):639-47. PubMed ID: 15630670
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamics and pharmacokinetics of the platelet GPIIb/IIIa inhibitor tirofiban in patients undergoing percutaneous coronary intervention: implications for adjustment of tirofiban and clopidogrel dosage.
Kimmelstiel C; Badar J; Covic L; Waxman S; Weintraub A; Jacques S; Kuliopulos A
Thromb Res; 2005; 116(1):55-66. PubMed ID: 15850609
[TBL] [Abstract][Full Text] [Related]
11. Targeting the platelet integrin GPIIb/IIIa.
Hagemeyer CE; Peter K
Curr Pharm Des; 2010; 16(37):4119-33. PubMed ID: 21247395
[TBL] [Abstract][Full Text] [Related]
12. Development of glycoprotein IIb-IIIa antagonists: translation of pharmacodynamic effects into clinical benefit.
Schneider DJ; Aggarwal A
Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):903-13. PubMed ID: 15500435
[TBL] [Abstract][Full Text] [Related]
13. Oral glycoprotein IIb/IIIa receptor inhibitors in patients with cardiovascular disease: why were the results so unfavourable.
Leebeek FW; Boersma E; Cannon CP; van de Werf FJ; Simoons ML
Eur Heart J; 2002 Mar; 23(6):444-57. PubMed ID: 11863347
[No Abstract] [Full Text] [Related]
14. Inhibitors of platelets glycoprotein IIb/IIIa (GP IIb/IIIa) receptor: rationale for their use in clinical cardiology.
Rossi ML; Zavalloni D
Mini Rev Med Chem; 2004 Sep; 4(7):703-9. PubMed ID: 15379638
[TBL] [Abstract][Full Text] [Related]
15. Practical issues of platelet glycoprotein IIb/IIIa receptor inhibition: saving lives and saving money.
Dippel EJ
Rev Cardiovasc Med; 2002; 3 Suppl 1():S28-34. PubMed ID: 12439434
[TBL] [Abstract][Full Text] [Related]
16. The evolving role of glycoprotein IIb/IIIa inhibitor therapy in contemporary care of acute coronary syndrome patients.
Tricoci P; Peterson ED
J Interv Cardiol; 2006 Oct; 19(5):449-55. PubMed ID: 17020570
[TBL] [Abstract][Full Text] [Related]
17. Progress in the field of GPIIb/IIIa antagonists.
Hanson J; de Leval X; David JL; Supuran C; Pirotte B; Dogné JM
Curr Med Chem Cardiovasc Hematol Agents; 2004 Apr; 2(2):157-67. PubMed ID: 15320798
[TBL] [Abstract][Full Text] [Related]
18. Role of platelet glycoprotein IIb/IIIa inhibitors in rescue percutaneous coronary interventions.
Petronio AS; De Carlo M; Rossini R; Amoroso G; Limbruno U; Ciabatti N; Palagi C; Caravelli P; Mariani M
Ital Heart J; 2004 Feb; 5(2):114-9. PubMed ID: 15086140
[TBL] [Abstract][Full Text] [Related]
19. Platelet glycoprotein IIb/IIIa receptor inhibitors: is their future as bright as their past?
Leesar MA
Catheter Cardiovasc Interv; 2008 Jun; 71(7):907-8. PubMed ID: 18498141
[No Abstract] [Full Text] [Related]
20. The emerging role of platelet glycoprotein IIb/IIIa inhibitors in managing high-risk patients with non-ST segment elevation acute coronary syndromes.
Bolognese L
Curr Med Res Opin; 2007 Jun; 23(6):1217-26. PubMed ID: 17559721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
